PPAR Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine Vielzahl von monoklonalen PPAR-Antikörpern für die fortgeschrittene Forschung in der Molekularbiologie. Die monoklonalen PPAR-Antikörper unterstützen zahlreiche experimentelle Anwendungen, darunter Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffineinbettungen (IHCP), Durchflusszytometrie (FCM) und Enzymimmunoassay (ELISA). Peroxisom-Proliferator-aktivierte Rezeptoren (PPARs) sind nukleare Rezeptoren, die die Genexpression regulieren, die am Lipidstoffwechsel, der Glukosehomöostase und an Entzündungen beteiligt sind. PPARs beeinflussen zahlreiche physiologische Prozesse und werden mit Stoffwechselstörungen, Herz-Kreislauf-Erkrankungen und Krebs in Verbindung gebracht. Das Verständnis der PPAR-Funktion ist entscheidend für die Entwicklung neuer therapeutischer Strategien. Weltweit nutzen Forscher monoklonale PPAR-Antikörper, um zelluläre Signalwege und molekulare Mechanismen zu erforschen. Monoklonale PPAR-Antikörper ermöglichen den präzisen Nachweis und die Analyse von Proteinexpressionsmustern unter verschiedenen Versuchsbedingungen. Die aktuelle Forschung mit monoklonalen PPAR-Antikörpern bringt immer wieder neue Erkenntnisse über die Stoffwechselregulation und den Krankheitsverlauf zutage. Die monoklonalen Antikörper von Santa Cruz Biotechnology unterstützen den wissenschaftlichen Fortschritt, indem sie zuverlässige Werkzeuge für die Erforschung der PPAR-Biologie und potenzielle therapeutische Anwendungen bereitstellen.
Siehe auch...
ChemCruz™ Chemikalien PPAR Inhibitoren or PPAR Aktivatoren für die funktionelle Analyse zellulärer Antworten auf PPAR
PPAR Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
PPARα Antikörper (H-2) | sc-398394 | mouse IgG2a κ | 1-98 (h) | WB, IP, IF, ELISA | m, r, h | 171 | ||
PPARα Antikörper (467D1a) | sc-130640 | mouse IgG1 | internal (h) | WB, IP | h | 11 | ||
PPARβ Antikörper (F-10) | sc-74517 | mouse IgG1 κ | 2-75 (m) | WB, IP, IF, ELISA | m, r, h | 52 | ||
PPARβ Antikörper (F-7) | sc-74440 | mouse IgG1 κ | 2-75 (h) | WB, IP, IF, IHC(P), ELISA | h | 9 | ||
PPARγ Antikörper (E-8) | sc-7273 | mouse IgG1 κ | 486-505 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 1,179 | ||
PPARγ Antikörper (B-5) | sc-271392 | mouse IgG1 λ | 8-106 (h) | WB, IP, IF, ELISA | m, r, h | 64 | ||
PPARγ Antikörper (8D1H8H4) | sc-81152 | mouse IgG1 | 77-272 (h) | WB, IF, IHC(P) | m, r, h | 11 | ||
PPARγ2 Antikörper (A-1) | sc-166731 | mouse IgG2a κ | 2-20 (h) | WB, IP, IF, IHC(P), ELISA | h | 20 | ||
PPARγ2 Antikörper (E-9) | sc-390740 | mouse IgG1 κ | 2-27 (m) | WB, IP, IF, IHC(P), ELISA | m, r, h | 10 |
PPAR CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
PPARα CRISPR/Cas9 KO Plasmid (h) | sc-400238 | h | Gene Knockout | GFP | 0 | ||
PPARα HDR Plasmid (h) | sc-400238-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PPARα Double Nickase Plasmid (h) | sc-400238-NIC | h | Gene Knockout | Puromycin | 0 | ||
PPARα Double Nickase Plasmid (h2) | sc-400238-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PPARα CRISPR/Cas9 KO Plasmid (m) | sc-422360 | m | Gene Knockout | GFP | 1 | ||
PPARα HDR Plasmid (m) | sc-422360-HDR | m | Homology Directed Repair | Puromycin | 1 | ||
PPARα Double Nickase Plasmid (m) | sc-422360-NIC | m | Gene Knockout | Puromycin | 1 | ||
PPARα Double Nickase Plasmid (m2) | sc-422360-NIC-2 | m | Gene Knockout | Puromycin | 1 | ||
PPARβ CRISPR/Cas9 KO Plasmid (h2) | sc-400523-KO-2 | h | Gene Knockout | GFP | 0 | ||
PPARβ Double Nickase Plasmid (h) | sc-400523-NIC | h | Gene Knockout | Puromycin | 0 | ||
PPARβ Double Nickase Plasmid (h2) | sc-400523-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PPARβ CRISPR/Cas9 KO Plasmid (m) | sc-422362 | m | Gene Knockout | GFP | 0 | ||
PPARβ HDR Plasmid (m) | sc-422362-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PPARβ Double Nickase Plasmid (m) | sc-422362-NIC | m | Gene Knockout | Puromycin | 0 | ||
PPARβ Double Nickase Plasmid (m2) | sc-422362-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PPARγ CRISPR/Cas9 KO Plasmid (h) | sc-400030 | h | Gene Knockout | GFP | 1 | ||
PPARγ HDR Plasmid (h) | sc-400030-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
PPARγ Double Nickase Plasmid (h) | sc-400030-NIC | h | Gene Knockout | Puromycin | 1 | ||
PPARγ Double Nickase Plasmid (h2) | sc-400030-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
PPARγ CRISPR/Cas9 KO Plasmid (m2) | sc-422363-KO-2 | m | Gene Knockout | GFP | 0 | ||
PPARγ HDR Plasmid (m2) | sc-422363-HDR-2 | m | Homology Directed Repair | Puromycin | 0 | ||
PPARγ Double Nickase Plasmid (m) | sc-422363-NIC | m | Gene Knockout | Puromycin | 0 | ||
PPARγ Double Nickase Plasmid (m2) | sc-422363-NIC-2 | m | Gene Knockout | Puromycin | 0 |
PPAR CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
PPARα CRISPR Activation Plasmid (h) | sc-400238-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARα CRISPR Activation Plasmid (h2) | sc-400238-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARα Lentiviral Activation Particles (h) | sc-400238-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARα Lentiviral Activation Particles (h2) | sc-400238-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARα CRISPR Activation Plasmid (m) | sc-422360-ACT | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
PPARα CRISPR Activation Plasmid (m2) | sc-422360-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
PPARα Lentiviral Activation Particles (m) | sc-422360-LAC | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
PPARα Lentiviral Activation Particles (m2) | sc-422360-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
PPARβ CRISPR Activation Plasmid (h) | sc-400523-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARβ CRISPR Activation Plasmid (h2) | sc-400523-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARβ Lentiviral Activation Particles (h) | sc-400523-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARβ Lentiviral Activation Particles (h2) | sc-400523-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARβ CRISPR Activation Plasmid (m) | sc-422362-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARβ CRISPR Activation Plasmid (m2) | sc-422362-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARβ Lentiviral Activation Particles (m) | sc-422362-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARβ Lentiviral Activation Particles (m2) | sc-422362-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARγ CRISPR Activation Plasmid (h) | sc-400030-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
PPARγ CRISPR Activation Plasmid (h2) | sc-400030-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
PPARγ Lentiviral Activation Particles (h) | sc-400030-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
PPARγ Lentiviral Activation Particles (h2) | sc-400030-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
PPARγ CRISPR Activation Plasmid (m) | sc-422363-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARγ CRISPR Activation Plasmid (m2) | sc-422363-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARγ Lentiviral Activation Particles (m) | sc-422363-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PPARγ Lentiviral Activation Particles (m2) | sc-422363-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
PPAR siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
PPARα siRNA (h) | sc-36307 | h | Gene Silencing | N/A | 31 | ||
PPARα siRNA (h2) | sc-44323 | h | Gene Silencing | N/A | 0 | ||
PPARα shRNA Plasmid (h) | sc-36307-SH | h | Gene Silencing | Puromycin | 31 | ||
PPARα shRNA Plasmid (h2) | sc-44323-SH | h | Gene Silencing | Puromycin | 0 | ||
PPARα shRNA (h) Lentivirale Partikel | sc-36307-V | h | Gene Silencing | Puromycin | 31 | ||
PPARα shRNA (h2) Lentivirale Partikel | sc-44323-V | h | Gene Silencing | Puromycin | 0 | ||
PPARα siRNA (m) | sc-36308 | m | Gene Silencing | N/A | 15 | ||
PPARα shRNA Plasmid (m) | sc-36308-SH | m | Gene Silencing | Puromycin | 15 | ||
PPARα shRNA (m) Lentivirale Partikel | sc-36308-V | m | Gene Silencing | Puromycin | 15 | ||
PPARβ siRNA (h) | sc-36305 | h | Gene Silencing | N/A | 15 | ||
PPARβ shRNA Plasmid (h) | sc-36305-SH | h | Gene Silencing | Puromycin | 15 | ||
PPARβ shRNA (h) Lentivirale Partikel | sc-36305-V | h | Gene Silencing | Puromycin | 15 | ||
PPARβ siRNA (m) | sc-36306 | m | Gene Silencing | N/A | 8 | ||
PPARβ shRNA Plasmid (m) | sc-36306-SH | m | Gene Silencing | Puromycin | 8 | ||
PPARβ shRNA (m) Lentivirale Partikel | sc-36306-V | m | Gene Silencing | Puromycin | 8 | ||
PPARγ siRNA (h) | sc-29455 | h | Gene Silencing | N/A | 83 | ||
PPARγ siRNA (h2) | sc-44220 | h | Gene Silencing | N/A | 4 | ||
PPARγ shRNA Plasmid (h) | sc-29455-SH | h | Gene Silencing | Puromycin | 83 | ||
PPARγ shRNA Plasmid (h2) | sc-44220-SH | h | Gene Silencing | Puromycin | 4 | ||
PPARγ shRNA (h) Lentivirale Partikel | sc-29455-V | h | Gene Silencing | Puromycin | 83 | ||
PPARγ shRNA (h2) Lentivirale Partikel | sc-44220-V | h | Gene Silencing | Puromycin | 4 | ||
PPARγ siRNA (m) | sc-29456 | m | Gene Silencing | N/A | 40 | ||
PPARγ siRNA (m2) | sc-43530 | m | Gene Silencing | N/A | 5 | ||
PPARγ shRNA Plasmid (m) | sc-29456-SH | m | Gene Silencing | Puromycin | 40 | ||
PPARγ shRNA Plasmid (m2) | sc-43530-SH | m | Gene Silencing | Puromycin | 5 | ||
PPARγ shRNA (m) Lentivirale Partikel | sc-29456-V | m | Gene Silencing | Puromycin | 40 | ||
PPARγ shRNA (m2) Lentivirale Partikel | sc-43530-V | m | Gene Silencing | Puromycin | 5 | ||
PPARγ siRNA (r) | sc-156077 | r | Gene Silencing | N/A | 7 | ||
PPARγ shRNA Plasmid (r) | sc-156077-SH | r | Gene Silencing | Puromycin | 7 | ||
PPARγ shRNA (r) Lentivirale Partikel | sc-156077-V | r | Gene Silencing | Puromycin | 7 | ||
PPARγ siRNA (ovine) | sc-156097 | ovine | Gene Silencing | N/A | 3 | ||
PPARγ shRNA Plasmid (ovine) | sc-156097-SH | ovine | Gene Silencing | Puromycin | 3 | ||
PPARγ shRNA (ovine) Lentivirale Partikel | sc-156097-V | ovine | Gene Silencing | Puromycin | 3 |
PPAR Transfected Lysates
| Empty Table Header | Produkt | Katnr. | Species | Empfohlener Primärantikörper | Referenzen | Bewertung |
|---|---|---|---|---|---|---|
PPARγ (m): 293T Lysate | sc-122729 | m | 0 | |||
PPARγ (h): 293T Lysate | sc-159760 | h | 0 |
PPAR Oligonucleotides
| Empty Table Header | Produkt | Übereinstimmende Katalognummer | Katalognummer Mutante | Übereinstimmung Mutante | Bindungsstelle | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
PPAR consensus oligonucleotide | sc-2587 | sc-2588 | 5'-AG GTC AAA GGT CA-3' | "GT"→"CA" | 40 |